LIFE09200604007 Tabish - Homi Bhabha National Institute

Bibliography
216. Bondy, M. L.; Wang, L. E.; El-Zein, R.; de Andrade, M.; Selvan, M. S.; Bruner, J. M.; Levin, V.
A.; Alfred Yung, W. K.; Adatto, P.; Wei, Q., Gamma-radiation sensitivity and risk of glioma. J
Natl Cancer Inst 2001, 93, (20), 1553-7.
217. Mahabir, S.; Wei, Q.; Barrera, S. L.; Dong, Y. Q.; Etzel, C. J.; Spitz, M. R.; Forman, M. R.,
Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 2008,
29, (5), 949- 56.
218. Li, D.; Firozi, P. F.; Wang, L. E.; Bosken, C. H.; Spitz, M. R.; Hong, W. K.; Wei, Q., Sensitivity
to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control
analysis. Cancer Res 2001, 61, (4), 1445-50.
219. Kuo, L. J.; Yang, L. X., Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In
Vivo 2008, 22, (3), 305-9.
220. Huang, X.; Darzynkiewicz, Z., Cytometric assessment of histone H2AX phosphorylation: a
reporter of DNA damage. Methods Mol Biol 2006, 314, 73-80.
221. Muslimovic, A.; Ismail, I. H.; Gao, Y.; Hammarsten, O., An optimized method for measurement
of gamma-H2AX in blood mononuclear and cultured cells. Nat Protoc 2008, 3, (7), 1187-93.
222. Kotsopoulos, J.; Chen, Z.; Vallis, K. A.; Poll, A.; Ainsworth, P.; Narod, S. A., DNA repair
capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers. Br J
Cancer 2007, 96, (1), 118-25.
223. Spitz, M. R.; Lippman, S. M.; Jiang, H.; Lee, J. J.; Khuri, F.; Hsu, T. C.; Trizna, Z.; Schantz, S.
P.; Benner, S.; Hong, W. K., Mutagen sensitivity as a predictor of tumor recurrence in patients
with cancer of the upper aerodigestive tract. J Natl Cancer Inst 1998, 90, (3), 243-5.
224. Spitz, M. R.; McPherson, R. S.; Jiang, H.; Hsu, T. C.; Trizna, Z.; Lee, J. J.; Lippman, S. M.;
Khuri, F. R.; Steffen-Batey, L.; Chamberlain, R. M.; Schantz, S. P.; Hong, W. K., Correlates of
mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol
Biomarkers Prev 1997, 6, (9), 687-92.
225. Weinert, T.; Lydall, D., Cell cycle checkpoints, genetic instability and cancer. Semin Cancer Biol
1993, 4, (2), 129-40.
226. Kaufmann, W. K.; Paules, R. S., DNA damage and cell cycle checkpoints. FASEB J 1996, 10, (2),
238-47.
227. Xiao, H.; Singh, S. V., p53 regulates cellular responses to environmental carcinogen
benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells. Cell Cycle 2007, 6, (14), 1753-
61.
228. Denissenko, M. F.; Pao, A.; Tang, M.; Pfeifer, G. P., Preferential formation of benzo[a]pyrene
adducts at lung cancer mutational hotspots in P53. Science 1996, 274, (5286), 430-2.
229. Meigs, J. B.; Shrader, P.; Sullivan, L. M.; McAteer, J. B.; Fox, C. S.; Dupuis, J.; Manning, A. K.;
Florez, J. C.; Wilson, P. W.; D'Agostino, R. B., Sr.; Cupples, L. A., Genotype score in addition to
common risk factors for prediction of type 2 diabetes. N Engl J Med 2008, 359, (21), 2208-19.
230. Kathiresan, S.; Melander, O.; Anevski, D.; Guiducci, C.; Burtt, N. P.; Roos, C.; Hirschhorn, J. N.;
Berglund, G.; Hedblad, B.; Groop, L.; Altshuler, D. M.; Newton-Cheh, C.; Orho-Melander, M.,
Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008,
358, (12), 1240-9.
231. Oguri, T.; Singh, S. V.; Nemoto, K.; Lazo, J. S.; The carcinogen (7R,8S)-dihydroxy-(9S,10R)-
epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene induces Cdc25B expression in human bronchial and
lung cancer cells. Cancer Res 2003;63, (4) 771-5.
161